Free Trial
ASX:SOM

SomnoMed (SOM) Stock Price, News & Analysis

About SomnoMed Stock (ASX:SOM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
95,124 shs
Average Volume
N/A
Market Capitalization
$136.15 million
P/E Ratio
N/A
Dividend Yield
2.25%
Price Target
N/A
Consensus Rating
N/A

Company Overview

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Receive SOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomnoMed and its competitors with MarketBeat's FREE daily newsletter.

SOM Stock News Headlines

What President Trump’s Executive Order 14154 means for your money
Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.
SomnoMed Limited Announces AGM Resolutions Approval
SomnoMed Projects Growth and Appoints New CFO
SomnoMed Limited Sees Growth and Innovation in 2024
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:SOM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.09
Net Income
$-12,240,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$91.65 million
Price / Cash Flow
7.61
Book Value
A$0.37 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$136.15 million
Optionable
Not Optionable
Beta
1.37
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (ASX:SOM) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners